• 목록
• 답변
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and nursing is challenging for women with the condition. There aren't enough data regarding how exposure over time may affect a foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological developmental disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to evaluate the benefits of using it against the potential dangers for the fetus. The doctors don't have the information to make unambiguous recommendations but they can provide information about risks and benefits to assist pregnant women to make informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers used a vast, population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during early pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to ensure that the classification was correct and to eliminate any bias.

The study conducted by the researchers was not without its limitations. The researchers were unable in the beginning to differentiate the effects of the medication from the disorder. That limitation makes it difficult to know whether the limited associations observed in the groups that were exposed are due to medication use or the confounding effect of comorbidities. The researchers also did not examine long-term outcomes for offspring.

The study did find that infants whose mothers had taken ADHD medication during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who took stimulant adhd medication in the uk medications during pregnancy also had a higher risk of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications during early pregnancies may be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, where possible, help them develop strategies to improve their coping abilities which can reduce the effects of her disorder on her daily functioning and relationships.

Interactions with Medication

Many doctors are faced with the decision of whether to maintain treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made in the absence of solid and reliable evidence in either case, which means that doctors must weigh their knowledge from their own experiences, those of other doctors, and what the research suggests on the subject as well as their best judgment for each individual patient.

Particularly, the issue of potential risks to the baby can be a challenge. Many of the studies on this issue are based on observational data rather than controlled research, and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which could underestimate the severity of teratogenic effects that could result in abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations by analyzing the data from deceased and live births.

The conclusion is that while some studies have shown an association between ADHD medications and the possibility of certain birth defects, others have found no connection, and most effective adhd medication for adults studies show a neutral or even slightly negative effect. As a result, a careful risk/benefit assessment must be done in each case.

For a lot of women with ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. The loss of medication can affect the ability to safely drive and complete work-related tasks, which are essential aspects of normal life for those suffering from ADHD.

She suggests women who are unsure about whether to continue or discontinue medication due to their pregnancy, consider the possibility of educating friends, family members, and coworkers on the condition, its impact on daily functioning, and the advantages of staying on the current treatment plan. It can also help a woman feel supported in her decision. It is important to remember that certain medications can pass through the placenta, therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug could be passed on to the baby.

Birth Defects and Risk of

As the use and misuse of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases the concern over the potential adverse effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Using two massive data sets researchers were able look at more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, first-trimester ADHD medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defects.

The authors of the study did not discover any link between early medication usage and congenital anomalies like facial deformities, or club feet. The results are in agreement with previous studies that have shown the existence of a slight, but significant increase in the number of cardiac malformations among women who began taking ADHD medication before the time of pregnancy. The risk increased in the latter stages of pregnancy when many women stopped taking their medication.

Women who took ADHD medication in the first trimester were more likely to need a caesarean or have a low Apgar after delivery and have a baby who needed breathing assistance at birth. The researchers of the study were not able to eliminate selection bias because they restricted the study to women without other medical conditions that might have contributed to the findings.

Researchers hope that their study will help doctors when they meet pregnant women. The researchers advise that, while discussing risks and benefits are important, the decision on whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and her needs.

The authors caution that, while stopping the medication is a possibility to consider, it is not advised due to the high prevalence of depression and mental health issues in women who are expecting or recently gave birth. Further, research shows that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.

Nursing

It can be a stressful experience to become a mom. Women suffering from ADHD can you get adhd medication Without a diagnosis (https://www.cheaperseeker.com/u/poundcoat2) face severe challenges when they must deal with their symptoms, go to doctor appointments and prepare for the birth of a child and adjust to new routines. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.

The risk to a breastfeeding infant is not too high since the majority of stimulant medications is absorbed through breast milk at a low level. However, the frequency of exposure to medication by the infant can differ based on dosage, how often it is administered and the time of day the medication is administered. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn is not yet fully known.

Because of the lack of evidence, some doctors may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a complicated decision for the patient, who must weigh the benefits different types of adhd medication continuing her medication against the potential risks to the embryo. As long as more information is available, GPs can inquire about pregnant patients whether they have a history of ADHD or if they are planning to take medication during the perinatal phase.

Numerous studies have proven that women can continue taking their ADHD medication without risk during pregnancy and while breast-feeding. In response, an increasing number of patients are choosing to do so. They have concluded after consulting with their doctors, that the benefits of continuing their current medication outweigh risk.

It is essential for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non medication treatment for adhd adults-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and reinforce coping mechanisms. This should include a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, and monitoring for signs of deterioration, and, if needed, adjustments to the medication regime.